Factors Likely to Have Influenced Earnings Results OncoSec Medical (NASDAQ:ONCS)


Earnings results for OncoSec Medical (NASDAQ:ONCS)

OncoSec Medical Incorporated is estimated to report earnings on 09/21/2020. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.1.

OncoSec Medical last posted its quarterly earnings results on June 15th, 2020. The biotechnology company reported ($0.45) earnings per share for the quarter, missing the consensus estimate of ($0.44) by $0.01. OncoSec Medical has generated $0.00 earnings per share over the last year. OncoSec Medical has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, September 21st, 2020 based off prior year’s report dates.

Analyst Opinion on OncoSec Medical (NASDAQ:ONCS)

4 Wall Street analysts have issued ratings and price targets for OncoSec Medical in the last 12 months. Their average twelve-month price target is $7.38, predicting that the stock has a possible upside of 63.89%. The high price target for ONCS is $10.00 and the low price target for ONCS is $5.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of “Buy.”

OncoSec Medical has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $7.38, OncoSec Medical has a forecasted upside of 63.9% from its current price of $4.50. OncoSec Medical has only been the subject of 4 research reports in the past 90 days.

Dividend Strength: OncoSec Medical (NASDAQ:ONCS)

OncoSec Medical does not currently pay a dividend. OncoSec Medical does not have a long track record of dividend growth.

Insiders buying/selling: OncoSec Medical (NASDAQ:ONCS)

In the past three months, OncoSec Medical insiders have bought 59,145.38% more of their company’s stock than they have sold. Specifically, they have bought $7,796,100.00 in company stock and sold $13,159.00 in company stock. Only 0.71% of the stock of OncoSec Medical is held by insiders. Only 4.03% of the stock of OncoSec Medical is held by institutions.

Earnings and Valuation of OncoSec Medical (NASDAQ:ONCS

Earnings for OncoSec Medical are expected to grow in the coming year, from ($2.79) to ($1.41) per share. OncoSec Medical has a P/B Ratio of 1.97. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

More latest stories: here